<DOC>
	<DOCNO>NCT02325570</DOCNO>
	<brief_summary>Multicenter , prospective , interventional open case series study use randomize split-mouth design moderate severe chronic periodontitis patient half-mouth treated KLOX BioPhotonic OraLum gel LED curing lamp adjunct conventional non-surgical periodontal treatment ( SRP ) versus SRP alone second ( control ) half-mouth .</brief_summary>
	<brief_title>Evaluation KLOX BioPhotonic OraLum Gel With LED Curing Lamp Moderate Severe Chronic Periodontitis</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<criteria>1 . Signed date write informed consent form ; 2 . Male female patient age 18 year old ; 3 . Good general health , free systemic disease diabetes , arthritis , HIV infection genetic disorder could influence outcome treatment ; 4 . Patient clinically confirm sign symptom generalize moderate severe chronic periodontitis ( define accord International Classification Periodontal Diseases , Armitage 1999 ) ; 5 . Patient periodontal treatment last year prior study ; 6 . Females childbearing potential must pregnant lactate study entry agree use adequate contraceptive method study . Inclusion Criteria Post Oral Hygiene Instructions ( OHI ) : 7 . Patient demonstrate sufficient plaque control indicate plaque score &lt; 30 % hygiene period ; 8 . Patient least two site quadrant probe pocket depth ( PPD ) equal 5 mm equal le 7 mm . 1 . Patient exist aggressive periodontitis ; 2 . Presence oral local mechanical factor ( ) could , opinion investigator , influence outcome study ; 3 . Presence orthodontic appliance , removable appliance , impinges tissue assess ; 4 . Soft hard tissue tumours oral cavity ; 5 . Systemic antibiotic therapy antiinflammatory drug medication ( ) might interfere periodontal healing within last three month prior study entry throughout study duration ; 6 . Patient participate clinical study within 30 day prior study entry throughout study duration ; 7 . Use anticoagulant warfarin , clopidogrel , enoxaparin high dos aspirin ( 162 mg daily ) ; 8 . Regular use chlorhexidine oral rinse / mouthwash ( Nonmedicated , counter , mouthwash acceptable ) ; 9 . Patient current alcohol abuse actively consume drug ( addiction ) ; may interfere patient 's ability comply study procedures 10 . Periodontal surgery plan study ; 11 . Female patient pregnant , nurse plan become pregnant within next 12 month ; 12 . Patient current smoker smoking use nicotine product ( ) last six month ; 13 . Concurrent disease ( porphyria ) drug ( ) ( methotrexate chloroquine ) know induce severe photosensitivity skin ; 14 . Patient ongoing malignant disease type , significant chronic disease , opinion investigator , might interfere evaluation study objective would result noncompliance study protocol ; 15 . Patients know hypersensitivity peroxide ; 16 . Patients known photosensitivity take drug treat photosensitivity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>